DGIFX
Price
$24.91
Change
+$0.09 (+0.36%)
Updated
Jul 3 closing price
Net Assets
553.52M
FSIDX
Price
$17.71
Change
+$0.08 (+0.45%)
Updated
Jul 3 closing price
Net Assets
5.21B
Interact to see
Advertisement

DGIFX vs FSIDX

Header iconDGIFX vs FSIDX Comparison
Open Charts DGIFX vs FSIDXBanner chart's image
Disciplined Growth Investors
Price$24.91
Change+$0.09 (+0.36%)
VolumeN/A
Net Assets553.52M
Fidelity Advisor Strategic Div & Inc I
Price$17.71
Change+$0.08 (+0.45%)
VolumeN/A
Net Assets5.21B
DGIFX vs FSIDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DGIFX vs. FSIDX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGIFX is a Buy and FSIDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSIDX has more cash in the bank: 5.21B vs. DGIFX (554M). FSIDX pays higher dividends than DGIFX: FSIDX (2.42) vs DGIFX (0.89). DGIFX was incepted earlier than FSIDX: DGIFX (14 years) vs FSIDX (22 years). DGIFX (0.78) is less costly to investors than FSIDX (0.67). FSIDX (36.00) and DGIFX (35.00) have comparable annual turnover. FSIDX has a lower initial minimum investment than DGIFX: FSIDX (0) vs DGIFX (10000). FSIDX annual gain was more profitable for investors over the last year : 9.23 vs. DGIFX (-15.01). FSIDX return over 5 years is better than : 38.30 vs. DGIFX (21.64).
DGIFXFSIDXDGIFX / FSIDX
Total Expense Ratio0.780.67116%
Annual Report Gross Expense Ratio0.780.67116%
Fund Existence14 years22 years-
Gain YTD1.2556.19220%
Front LoadN/AN/A-
Min. Initial Investment100000-
Min. Initial Investment IRAN/AN/A-
Net Assets554M5.21B11%
Annual Yield % from dividends0.892.4237%
Returns for 1 year-15.019.23-163%
Returns for 3 years36.8222.53163%
Returns for 5 years21.6438.3057%
Returns for 10 years62.3248.91127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MODV3.250.11
+3.50%
ModivCare
GANX1.690.06
+3.36%
Gain Therapeutics
RMBS65.890.89
+1.37%
Rambus
AVDL8.930.12
+1.36%
Avadel Pharmaceuticals plc
BOWNU13.02N/A
N/A
Bowen Acquisition Corp